Inborn errors of immunity associated with characteristic phenotypes

[1]  A. Gennery,et al.  Update on DNA-Double Strand Break Repair Defects in Combined Primary Immunodeficiency , 2020, Current Allergy and Asthma Reports.

[2]  O. Mäkitie,et al.  Immunodeficiency in cartilage‐hair hypoplasia: Pathogenesis, clinical course and management , 2020, Scandinavian journal of immunology.

[3]  K. Schwarz,et al.  T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency , 2020, Journal of Clinical Immunology.

[4]  J. Casanova,et al.  Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee , 2020, Journal of Clinical Immunology.

[5]  A. Aghamohammadi,et al.  Ataxia‐telangiectasia: A review of clinical features and molecular pathology , 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[6]  A. Worth,et al.  How I manage patients with Wiskott Aldrich syndrome , 2019, British journal of haematology.

[7]  A. Aghamohammadi,et al.  The First Purine Nucleoside Phosphorylase Deficiency Patient Resembling IgA Deficiency and a Review of the Literature , 2019, Immunological investigations.

[8]  A. Freeman,et al.  An Update on Syndromes with a Hyper-IgE Phenotype. , 2019, Immunology and allergy clinics of North America.

[9]  K. Sullivan.  Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2019, Immunological reviews.

[10]  H. Ochs,et al.  Hyper IgE syndromes: clinical and molecular characteristics , 2018, Immunology and cell biology.

[11]  K. Sullivan,et al.  Variable immune deficiency related to deletion size in chromosome 22q11.2 deletion syndrome , 2018, American journal of medical genetics. Part A.

[12]  J. Casanova,et al.  Human hyper-IgE syndrome: singular or plural? , 2018, Mammalian Genome.

[13]  A. Zauber,et al.  Health supervision for people with Bloom syndrome , 2018, American journal of medical genetics. Part A.

[14]  J. Bussel,et al.  Screening for Wiskott-Aldrich syndrome by flow cytometry. , 2018, The Journal of allergy and clinical immunology.

[15]  A. Schäffer,et al.  ZNF341 controls STAT3 expression and thereby immunocompetence , 2018, Science Immunology.

[16]  T. Crawford,et al.  Chromosome instability syndromes , 2018, Nature Reviews Disease Primers.

[17]  D. Campbell,et al.  Immunodeficiency in CHARGE syndrome , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[18]  K. Sullivan,et al.  The immune deficiency of chromosome 22q11.2 deletion syndrome , 2017, American journal of medical genetics. Part A.

[19]  Kim Blake,et al.  CHARGE Syndrome , 2017, Pediatrics in Review.

[20]  T. Crawford,et al.  Ataxia telangiectasia: a review , 2016, Orphanet Journal of Rare Diseases.

[21]  Colin A. Johnson,et al.  A homozygous STIM1 mutation impairs store-operated calcium entry and natural killer cell effector function without clinical immunodeficiency , 2016, The Journal of allergy and clinical immunology.

[22]  D. Lewis,et al.  Schimke Immunoosseous Dysplasia , 2016 .

[23]  G. Matthijs,et al.  Clinical Utility Gene Card for: PGM3 defective congenital disorder of glycosylation , 2015, European Journal of Human Genetics.

[24]  C. Boerkoel,et al.  Insights into the Renal Pathogenesis in Schimke Immuno-Osseous Dysplasia , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  Peter Hsu,et al.  CHARGE syndrome: A review , 2014, Journal of paediatrics and child health.

[26]  D. Buchbinder,et al.  Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments , 2014, The application of clinical genetics.

[27]  A. Cohen,et al.  Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies , 2013, Current opinion in allergy and clinical immunology.

[28]  R. Geha,et al.  Wiskott‐Aldrich syndrome: a comprehensive review , 2013, Annals of the New York Academy of Sciences.

[29]  Amos J. Simon,et al.  Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency , 2013, Immunologic research.

[30]  S. Ehl,et al.  The European internet‐based patient and research database for primary immunodeficiencies: update 2011 , 2012, Clinical and experimental immunology.

[31]  L. Fairbanks,et al.  Purine Nucleoside Phosphorylase Deficiency: A Mutation Update , 2011, Nucleosides, nucleotides & nucleic acids.

[32]  E. McDermott,et al.  A novel NEMO gene mutation causing osteopetrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID) , 2010, European Journal of Pediatrics.

[33]  V. Micheli,et al.  Pediatric neurological syndromes and inborn errors of purine metabolism , 2010, Neurochemistry International.

[34]  A. Fischer,et al.  ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. , 2009, The Journal of allergy and clinical immunology.

[35]  A. Verloes.  Updated diagnostic criteria for CHARGE syndrome: A proposal , 2005, American journal of medical genetics. Part A.

[36]  R. Gatti,et al.  Ataxia-telangiectasia, an evolving phenotype. , 2004, DNA repair.

[37]  O. Mäkitie.  Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. , 1992, Journal of medical genetics.